Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

MedTech’s next decade: infrastructure to define the winners

Analysis Nick Herbert -
For decades, the medical technology sector has been defined by product innovation. Companies competed by developing devices that were incrementally better: a more precise surgical instrument, a more durable implant, or a more flexible catheter. A new device would launch with slightly better outcomes, gain adoption, and then be...

Switzerland: Galderma buys back CHF232m as EQT, ADIA and Auba fully divest remaining stake

Cosmetic & Aesthetics Nick Herbert -
SIX-listed Galderma, the pure-play dermatology category leader, has agreed to repurchase 1.6 million shares at a price of CHF143.75 per share for a total consideration of CHF232m (US$298m) in an accelerated bookbuild offering (ABO) of Galderma shares by Sunshine SwissCo (EQT), Abu Dhabi Investment Authority (ADIA) and Auba Investment launched 10 March. The repurchase was made at the same price per share determined by the bookbuilding offering. As a result of yesterday evening’s ABO, the selling shareholders have fully divested their remaining stake in Galderma. It bring an end to a series of share sales by the selling shareholder...